HOME >> BIOLOGY >> NEWS
Green tea and COX-2 inhibitors combine to slow growth of prostate cancer

PHILADELPHIA -- Drinking a nice warm cup of green tea has long been touted for its healthful benefits, both real and anecdotal. But now researchers have found that a component of green tea, combined with low doses of a COX-2 inhibitor, could slow the spread of human prostate cancer.

In the March 1 issue of Clinical Cancer Research, researchers from University of Wisconsin-Madison demonstrate that low doses of the COX-2 inhibitor celecoxib, administered with a green tea polyphenol called pigallocatechin-3-gallate (EGCG), can slow the growth of human prostate cancer. Their experiments were performed in cell cultures and in a mouse model for the disease.

Celecoxib and green tea have a synergistic effect -- each triggering cellular pathways that, combined, are more powerful than either agent alone, said Hasan Mukhtar, Ph.D., professor of dermatology at the University of Wisconsin and member of Wisconsins Paul Carbone Comprehensive Cancer Center. We hope that a clinical trial could lead to a preventative treatment as simple as tea time.

Previous research has linked the cyclooxygenase-2 enzyme, commonly known as COX-2, to many cancer types, including prostate cancer, said Mukhtar. Mukhtar and his colleagues have previously shown COX-2 inhibitors like celecoxib (known under the brand name Celebrex) suppress prostate cancer in animal models. COX-2 inhibitors also have been shown to cause adverse cardiovascular effects when administered at high doses over long durations.

In 2004, Mukhtar and his colleagues demonstrated that green tea polyphenol EGCG has cancer-fighting abilities of its own. Their study, published in Cancer Research, showed that EGCG can modulate the insulin-like growth factor-1 (IGF-1)-driven molecular pathway in a mouse model for human prostate cancer, pushing the cells toward programmed cell death (apoptosis).

We believed that COX-2 inhibitors may still prove beneficial if used in combination
'"/>

Contact: Greg Lester
lester@aacr.org
267-646-0554
American Association for Cancer Research
1-Mar-2007


Page: 1 2 3

Related biology news :

1. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
2. Greenlands ancient forests shed light on stability of ice sheet
3. Green Junta
4. Green Nanotechnology: Its Easier Than You Think
5. Stevens Center for Science Writings honors Edward O. Wilson with Green Book Award
6. Green payments are the future of agricultural support
7. Green Chemical Reactor Engineering -- XI
8. Climate changes are linked between Greenland and the Antarctic
9. Green plants share bacterial toxin
10. Mary Frances Lyon to receive Rockefellers Pearl Meister Greengard Prize
11. Green sturgeon receives threatened status

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/13/2019)... ... March 13, 2019 , ... Leak Detection Associates , the leading global ... Industries, is excited to announce that it will be returning to INTERPHEX ... newly installed and highly experienced management team immediately marked Interphex as the show ...
(Date:3/9/2019)... Calif. (PRWEB) , ... March 07, 2019 , ... ... of a full day workshop presented by University of California Riverside’s EPIC ... held from 8 a.m. to 6 p.m. on Tuesday, March 17, 2019. The location ...
(Date:3/9/2019)... ... March 08, 2019 , ... Ace Laboratories, ... Well-Mints™ resveratrol + ribose hard candy lozenges ( http://www.well-mints.com ). , Well-Mints™ each ... flavored hard candy base dusted with powdered sugar. , Well-Mints'™ patented technology delivers ...
Breaking Biology News(10 mins):
(Date:3/12/2019)... (PRWEB) , ... March 11, 2019 , ... ... first hospital system in Colorado, and among the first in the nation, to ... around lab draws, IV placement and overall degree to which staff showed compassion ...
(Date:3/11/2019)... ... ... In this live webinar, the featured speakers will focus on the many attributes that ... how to use the information they have from the protocol and clinical trial knowledge, ... is properly designed and set up to ensure flawless execution. As clinical trial success ...
(Date:3/9/2019)... SAN DIEGO (PRWEB) , ... March 07, 2019 ... ... Agilent Technologies, is a pioneer in the development and commercialization of high performance, ... and PhysioStim, a leading European CRO with GLP-certified expertise in cardiovascular pharmacology and ...
(Date:3/5/2019)... ... March 05, 2019 , ... San Fransisko, or Sisko ... purchased him at four years old to pursue a career in dressage. According ... the most talented horse that she’d ever worked with. Unfortunately, Sisko suffered an ...
Breaking Biology Technology:
Cached News: